Correlation Between Hookipa Pharma and Allogene Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Allogene Therapeutics, you can compare the effects of market volatilities on Hookipa Pharma and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Allogene Therapeutics.

Diversification Opportunities for Hookipa Pharma and Allogene Therapeutics

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Hookipa and Allogene is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Allogene Therapeutics go up and down completely randomly.

Pair Corralation between Hookipa Pharma and Allogene Therapeutics

Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Allogene Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.38 times less risky than Allogene Therapeutics. The stock trades about -0.36 of its potential returns per unit of risk. The Allogene Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  280.00  in Allogene Therapeutics on August 25, 2024 and sell it today you would lose (59.00) from holding Allogene Therapeutics or give up 21.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Hookipa Pharma  vs.  Allogene Therapeutics

 Performance 
       Timeline  
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Allogene Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allogene Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Hookipa Pharma and Allogene Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hookipa Pharma and Allogene Therapeutics

The main advantage of trading using opposite Hookipa Pharma and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.
The idea behind Hookipa Pharma and Allogene Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges